Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Godex in Patients With Nonalcoholic Fatty Liver Disease
NCT06152991Phase 3Enrolling by invitation
- Sponsor
- Yoon Jun Kim
- Start
- Sep 2023
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Godex in non-alcoholic fatty liver disease (NAFLD), sponsored by Yoon Jun Kim. Started Sep 2023; status: enrolling by invitation.
02
Drugs
Godex
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT06152991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06152991.